Literature DB >> 22197607

The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory.

Johannes M W van den Ouweland1, Ido P Kema.   

Abstract

Liquid chromatography coupled to mass spectrometry (LC-MS/MS) is increasingly used as a routine methodology in clinical laboratories for the analysis of low molecular weight molecules. The high specificity in combination with high sensitivity and multi-analyte potential makes it an attractive complementary method to traditional methodology used for routine applications. Its strength and weaknesses in this context will be discussed and examples of successful clinical applications will be given. For LC-MS/MS to truly fulfil its promise in clinical diagnosis, the prerequisite steps being sample pre-treatment, chromatographic separation and detection by selected reaction monitoring must become more integrated as they are in conventional clinical analysers. The availability of ready-to-use reagents kits, eliminating efforts needed for method development and extensive validation, are likely to contribute to a wider acceptance of LC-MS/MS in clinical laboratories. Growing applicability of LC-MS/MS in the clinical laboratory field is expected from quantitative protein analysis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Year:  2011        PMID: 22197607     DOI: 10.1016/j.jchromb.2011.11.044

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  14 in total

1.  Measurement of urinary free cortisol by LC-MS-MS: adoption of a literature reference range and comparison with our current immunometric method.

Authors:  L Bianchi; B Campi; M R Sessa; G De Marco; E Ferrarini; R Zucchi; C Marcocci; P Vitti; L Manetti; A Saba; P Agretti
Journal:  J Endocrinol Invest       Date:  2019-04-22       Impact factor: 4.256

Review 2.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis.

Authors:  Phillip J Monaghan; Brian G Keevil; Peter J Trainer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

3.  An LC-MS/MS method for serum methylmalonic acid suitable for monitoring vitamin B12 status in population surveys.

Authors:  Ekaterina M Mineva; Mindy Zhang; Daniel J Rabinowitz; Karen W Phinney; Christine M Pfeiffer
Journal:  Anal Bioanal Chem       Date:  2014-09-26       Impact factor: 4.142

4.  Quantitative UPLC-MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency.

Authors:  Margret Thorsteinsdottir; Unnur A Thorsteinsdottir; Finnur F Eiriksson; Hrafnhildur L Runolfsdottir; Inger M Sch Agustsdottir; Steinunn Oddsdottir; Baldur B Sigurdsson; Hordur K Hardarson; Nilesh R Kamble; Snorri Th Sigurdsson; Vidar O Edvardsson; Runolfur Palsson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-09-14       Impact factor: 3.205

5.  Non-neuronal release of gamma-aminobutyric Acid by embryonic pluripotent stem cells.

Authors:  Lin Teng; Ya-Bin Tang; Fan Sun; Shi-Min An; Chun Zhang; Xin-Jie Yang; Hao-Yu Lv; Qin Lu; Yong-Yao Cui; Jin-Jia Hu; Liang Zhu; Hong-Zhuan Chen
Journal:  Stem Cells Dev       Date:  2013-08-02       Impact factor: 3.272

6.  Insights and prospects for ion mobility-mass spectrometry in clinical chemistry.

Authors:  David C Koomen; Jody C May; John A McLean
Journal:  Expert Rev Proteomics       Date:  2022-01-17       Impact factor: 3.940

7.  Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Marco Mezzullo; Valentina Vicennati; Carla Pelusi; Renato Pasquali; Uberto Pagotto
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

8.  UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays.

Authors:  Joachim Kuhn; Tatjana Gripp; Tobias Flieder; Marcus Dittrich; Doris Hendig; Jessica Busse; Cornelius Knabbe; Ingvild Birschmann
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

9.  Personalized Proteomics: The Future of Precision Medicine.

Authors:  Trevor T Duarte; Charles T Spencer
Journal:  Proteomes       Date:  2016-10-01

10.  Pathology interface for the molecular analysis of tissue by mass spectrometry.

Authors:  Jeremy L Norris; Tina Tsui; Danielle B Gutierrez; Richard M Caprioli
Journal:  J Pathol Inform       Date:  2016-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.